[HTML][HTML] Stem cells therapy as a possible therapeutic option in treating COVID-19 patients

D Esquivel, R Mishra, P Soni, R Seetharaman… - Stem cell reviews and …, 2021 - Springer
An unfortunate emergence of a new virus SARS-CoV-2, causing a disease known as COVID-
19, has spread all around the globe and has caused a pandemic. It primarily affects the …

[HTML][HTML] Stem cells therapy for COVID-19: a systematic review and meta-analysis

E Arabpour, S Khoshdel, N Tabatabaie… - Frontiers in …, 2021 - frontiersin.org
Introduction: Since its primary detection on December 2019 in China, COVID-19 have been
caused more than 175 million infected cases and 3.7 million deaths up to 10 June 2021 …

[HTML][HTML] Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19

S Yasamineh, HG Kalajahi, P Yasamineh… - Stem Cell Research & …, 2022 - Springer
The SARS-COV-2 virus has infected the world at a very high rate by causing COVID-19
disease. Nearly 507 million individuals have been infected with this virus, with …

[HTML][HTML] Mesenchymal stem cells for coronavirus (COVID-19)-induced pneumonia: revisiting the paracrine hypothesis with new hopes?

S Öztürk, AE Elçin, YM Elçin - Aging and disease, 2020 - ncbi.nlm.nih.gov
Mesenchymal stem cells (MSCs) bear a promising potential for regenerative medicine
therapies and they repair damaged tissue through secretion of immune modulatory and anti …

[HTML][HTML] Review of trials currently testing stem cells for treatment of respiratory diseases: facts known to date and possible applications to COVID-19

F Majolo, GL da Silva, L Vieira, LFSM Timmers… - Stem cell reviews and …, 2021 - Springer
Therapeutic clinical and preclinical studies using cultured cells are on the rise, especially
now that the World Health Organization (WHO) declared coronavirus disease 2019 (COVID …

[HTML][HTML] Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome

F Lin, TE Ichim, S Pingle, LD Jones… - World journal of stem …, 2020 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19), a pandemic disease caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV2), is growing at an exponential rate …

Mesenchymal stem cells: a new front emerges in coronavirus disease 2019 treatment

SS Raza, MA Khan - Cytotherapy, 2022 - Elsevier
Currently, treating coronavirus disease 2019 (COVID-19) patients, particularly those afflicted
with severe pneumonia, is challenging, as no effective pharmacotherapy for severe acute …

Feasibility of mesenchymal stem cell therapy for COVID-19: a mini review

J Li, X Wang, N Li, Y Jiang, H Huang… - Current Gene …, 2020 - ingentaconnect.com
Patients infected with SARS-CoV-2 carry the coronavirus disease 2019 (COVID-19) which
involves multiple systems and organs with acute respiratory distress syndrome (ARDS) as …

[HTML][HTML] Mesenchymal stem cells (MSCs) as a potential therapeutic strategy in COVID-19 patients: literature research

A Coelho, RD Alvites, MV Branquinho… - Frontiers in cell and …, 2020 - frontiersin.org
In 2019, an outbreak of an unknown coronavirus–SARS-CoV-2–responsible for COVID-19
disease, was first reported in China, and evolved into a pandemic of huge dimensions and …

[HTML][HTML] Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review

S Mahendiratta, S Bansal, P Sarma, H Kumar… - Biomedicine & …, 2021 - Elsevier
Abstract Background SARS-CoV-2, which majorly affects the lungs and respiratory tract is
thought due to dysregulation of the immune system which causes an immense imbalance of …